The identification of the tubular TLR2/NF-κB/CCL2 signaling pathway and the inhibition of the TLR4/NF-κB pathway represent promising strategies for addressing purulent AKI and related renal injuries in sepsis. The gene discussed is CCL2; the disease is acute kidney injury.